# Safety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury With Shoulder Adhesion: A Prospective, Multicenter, Randomized Controlled Trial

> **NCT07348016** · NA · RECRUITING · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 70 (estimated)

## Conditions studied

- Rotator Cuff Injuries
- Adhesions

## Interventions

- **DRUG:** Liposomal Bupivacaine + Compound Betamethasone Injection
- **DRUG:** Compound Betamethasone Injection

## Key facts

- **NCT ID:** NCT07348016
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-07-30
- **Final completion:** 2028-12-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07348016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07348016, "Safety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury With Shoulder Adhesion: A Prospective, Multicenter, Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07348016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
